ICCC · Immucell Corp /De/ · Insider Trading

The stock option vests as follows: 3,977 shares becoming exercisable on each of April 15, 2027 and April 15, 2028, and 3,979 shares becoming exercisable on April 15, 2029.

The stock option vests as follows: 3,977 shares becoming exercisable on each of April 15, 2027 and April 15, 2028, and 3,979 shares becoming exercisable on April 15, 2029.

The stock option vests as follows: 5,966 shares becoming exercisable on each of April 15, 2027 and April 15, 2028, and 5,967 shares becoming exercisable on April 15, 2029.

The stock option vests as follows: 3,977 shares becoming exercisable on each of April 15, 2027 and April 15, 2028, and 3,979 shares becoming exercisable on April 15, 2029.

Number of shares surrendered to the Issuer in payment of the exercise price of the option.

Number of shares resulting from stock-for-stock exercise of stock option. The Reporting Person surrendered previously owned shares in full payment of the exercise price for that option.

This amendment amends the previously reported transaction effective on 1/27/2026 to disclose the correct number of shares included in the option award.

Option grant made to Mr. te Boekhorst in connection with his employment as President and CEO. The option shall be treated as an incentive stock option to the maximum extent permitted by the Internal Revenue Code of 1986, as amended, with the balance treated as nonqualified stock option. One hundred percent of the stock option will vest when the Issuer's net operating income for four consecutive calendar quarters equals or exceeds 300% of the Issuer's audited net operating income for its 2025 fiscal year.

Option grant made to Mr. Fiori in connection with his employment as Chief Financial Officer. The option shall be treated as an incentive stock option to the maximum extent permitted by the International Revenue Code of 1986, as amended, with the balance treated as a nonqualified stock option. The stock option vests as follows: 40,000 options on the first, second and third anniversary of the grant date.

Option grant made to Ms. Brockmann in connection with her employment as Vice President of Sales and Marketing. The option shall be treated as an incentive stock option to the maximum extent permitted by the Internal Revenue Code of 1986, as amended, with the balance treated as a nonqualified stock option. The stock option vests as follows: 33,333 shares becoming exercisable on each of January 27, 2027 and January 27, 2028 and 33,334 shares becoming exercisable on January 27, 2029.

This amendment amends the previously reported transaction effective on 12/3 to disclose the correct amount and price of shares purchased, and the correct transaction date.

This amendment amends the previously reported transaction effective on 12/3 to disclose the correct amount and price of shares purchased.

Option grant made to Mr. te Boekhorst in connection with his commencement of employment as President and CEO. The option shall be treated as an incentive stock option to the maximum extent permitted by the Internal Revenue Code of 1986, as amended, with the balance treated as a nonqualified stock option. The stock option vests as follows: 24,759 options on the first, second, and third anniversary of the grant date.

(2) Original stock option was for 15,000 shares. These shares resulted from a net exercise transaction, with 11,470 shares withheld (credited at $6.29 per share, the closing price of the Common stock on the date of exercise) in payment of the exercise price for 3,530 shares.

(2) Original stock option was for 15,000 shares. These shares resulted from a net exercise transaction, with 11,470 shares withheld (credited at $6.29 per share, the closing price of the Common stock on the date of exercise) in payment of the exercise price for 3,530 shares.

(1) Shares acquired in stock option net exercise transaction with the Issuer.

(1) This figure includes 6,987 shares of common stock held by immediate family members of Dr. Tomsche.

(1) This figure includes 6,987 shares of common stock held by immediate family members of Dr. Tomsche.

(1) This figure includes 6,987 shares of common stock held by immediate family members of Dr. Tomsche.

1. This figure includes 6,987 shares of common stock held by immediate family members of Dr. Tomsche.

1. This figure includes 6,987 shares of common stock held by immediate family members of Dr. Tomsche.

1. This figure includes 6,987 shares of common stock held by immediate family members of Dr. Tomsche.